Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China
Jun Guo(Tianjin University of Science and Technology), Chao Quan(University of California, Davis), Zhanhang Wang(Guangdong 999 Brain Hospital), Shougang Guo(Shandong Provincial Hospital), Sheng Chen(Shanghai Jiao Tong University), Huiru Xue(Shanxi Medical University), Huan Yang(Central South University), Zhe Wu(First Hospital of China Medical University), Yongfeng Xu(Second Affiliated Hospital of Zhejiang University), Xiaomu Wu(Nanchang University), Yinan Zhao(Capital Medical University), Hui Liang(First Affiliated Hospital Zhejiang University), Qiang Dong(Henan Normal University), Chun‐Sheng Yang(Tianjin Medical University General Hospital), De‐Cai Tian(Capital Medical University), Chunyang Li(Jiangsu Academy of Agricultural Sciences), Lihua Wang(Jiangxi University of Traditional Chinese Medicine), Wenyu Li(Sir Run Run Shaw Hospital), Yanlin Zhang(Soochow University), Yu Zhang(Sun Yat-sen University), Hongbo Liu(First Affiliated Hospital of Zhengzhou University), Honghao Wang(Southwest Jiaotong University), Bitao Bu(Tongji Hospital), Hongyu Zhou(Xinjiang Uygur Autonomous Region Uygur Medicine Hospital), Jiayong Wu(Nanjing Medical University), Jiawei Wang(Qilu University of Technology)
Cited by 10
Related Papers
Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers
|Nucleic Acids Research|2015|386
Biomarkers of aging
|Science China Life Sciences|2023|362
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
|Nature Medicine|2011|351
Plasma proteomic profiles predict future dementia in healthy adults
|Nature Aging|2024|258